[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2002, 28(6) 368-371 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
��������
�Ŵ�ѧ
����
���������������
�����
����
PubMed
Article by
Article by

����ά�����Ŵ�������о���չ

�����, ����

�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ�210042

ժҪ��

����ά�����dz����ij�Ⱦɫ�������Ŵ��Լ���,������������ά�����Ŵ��ͻ����о�ȡ���˺ܴ��չ,ͨ�����������͡������¡����������˸ò���������,ͻ�估������Ϣ��������Ҫ�����˸ò�1�ͼ�2�ͻ���λ��ͻ��ȷ����Ŵ�ѧ����Ľ�չ��

�ؼ����� ����ά����   �Ŵ�ѧ   ����  

Abstract:

Keywords:
�ո����� 2002-01-11 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] O'Connell P, Leach RJ, Ledbetter DH, et al. Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type ��. Am J Hum Genet, 1989,44(1):51-57.
[2] Li Y, O'Connell P, Breidenbach HH, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics, 1995, 25 (1):9-18.
[3] Marchuk DA, Saulino AM, Tavakkol R, et al. cDNA cloning of the type �� neurofibromatosis gene:complete sequence of the NF1 gene product. Genomics, 1991,11 (4):931-940.
[4] Osborn M, Cooper DN, Upadhyaya M. Molecular analysis of the 5'-flanking region of the neurofibromatosis type 1 (NF1) gene:identification of five sequence variants. Clin Genet, 2000, 57(3):221-224.
[5] Buske A, Gewies A, Lehmann R, et al. Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1).Am J Med Genet, 1999, 86(4):328-330.
[6] Maynard J, Krawczak M, Upadhyaya M. Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Hum Genet, 1997, 99(5):674-676.
[7] Park VM, Kenwright KA, Sturtevant DB, etal. Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene. Hum Genet,1998, 103(4):382-385.
[8] Klose A, Robinson N, Gewies A, et al. Two novel mutations in exons 19a and 20 and a BsaBI [ correction of BsaI] polymorphism in a newly characterized intron of the neurofibromatosis type 1 gene. Hum Genet,1998, 102(3):367-371.
[9] Fang LJ, Simard MJ, Vidaud D, et al. A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition. J Mol Biol, 2001,307(5):1261-1270.
[10] Boulandet EG, Pantel J, Cazeneuve C,et al. NF1 gene analysis focused on CpG-rich exons in a cohort of 93 patients with neurofibromatosis type 1. Hum Mutat, 2000, 16(3):274-275.
[11] Park KC, Choi HO, Han WS, et al. Identification of two novel frame shift mutations of the NF1 gene in Korean patients with neurofibromatosis type 1. J Korean Med Sci, 2000, 15(5):542-544.
[12] Park KC, Choi HO, Park KH, et al. A nonsense mutation at Arg1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient. J Hum Genet, 2000;45(2):84-85.
[13] Upadhyaya M, Osborn MJ, Maynard J, et al. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet,1997, 99(1):88-92.
[14] Rasmussen SA, Colman SD, Ho VT, et al. Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet,1998, 35 (6):468-471.
[15] Tinschert S, Naumann I, Stegmann E, et al. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1(NF1) gene. EurJ Hum Genet, 2000, 8(6):455-459.
[16] Eisenbarth I, Beyer K, Krone W, et al. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum G enet, 2000, 66(2):393-401.
[17] Arai E, Ikeuchi T, Karasawa S, et al. Constitutional translocation t (4 ;22) (q12; q12.2) associated with neurofibromatosis type 2. Am J Med Genet, 1992, 44 (2):163-167.
[18] Zucman-Rossi J, Legoix P, Der Sarkissian H, et al. NF2 gene in neurofibromatosis type 2 patients. Hum Mol Genet, 1998, 7 (13):2095-2101.
[19] 0Bruder CE, Ichimura K, Blennow E,et al. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22:possible localization of a neurofibromatosis type 2modifier gene? Genes Chromosomes Cancer, 1999, 25 (2):184-190.
[20] Kehrer-Sawatzki H, Udart M, Krone W,et al. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2. Hum Genet, 1997, 100(1):67-74.
[21] Jacoby LB, MacCollin M, Parry DM, et al. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Neurogenetics,1999, 2(2):101-108.
[22] Bourn D, Carter SA, Mason S, et al. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene. Hum Mol Genet, 1994, 3(5):813-816.
[23] Sestini R, Vivarelli R, Balestri P, et al. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene. Hum Genet,2000, 107(4):366-371.
[24] Kluwe L, Friedrich RE, Hagel C, et al. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors. J Invest Dermatol, 2000, 114 (5):1017-1021.
[25] Spiegel R, Machler M, Stocker HP, et al. Neurofibromatosis Type 1:genetic studies with DNA markers in 38 families. Schweiz Med Wochenschr, 1991, 121 (40):1445-1452.
[26] Mautner VF, Laute S, Schneider E, et al. Neurofibromatosis:current clinical and molecular genetic aspects from the neurologic viewpoint.Nervenarzt, 1991,62(6):340-348.
�������������
1���쾴������, ��Ԫ����У.����ά�����ķ����Ŵ�ѧ��չ[J]. ����Ƥ���Բ�ѧ��־, 1996,22(4): 203-205

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־